Beyond the APC era Alternative pathways to CRC. Jeremy R Jass McGill University

Size: px
Start display at page:

Download "Beyond the APC era Alternative pathways to CRC. Jeremy R Jass McGill University"

Transcription

1 Beyond the APC era Alternative pathways to CRC Jeremy R Jass McGill University

2 Outline Limitations of APC model KRAS and serrated polyps CRC and CpG island methylation Serrated pathway to CRC Fusion pathways

3 Adenoma-carcinoma sequence APC KRAS TP53 Normal Small adenoma Large adenoma Cancer Genetic instability

4 Familial adenomatous polyposis

5 Mutation in sporadic colorectal neoplasia Dys ACF TAD CRC APC 19% 33% 60% KRAS 63% 11% 35% TP53 0% 0% 50% B-CAT 0% 13% 0%

6 Interpretation of mutational spectrum in colorectal neoplasms Minute adenomas initiated by APC or KRAS Mutation of APC and KRAS can occur during progression to CRC Progression to CRC is more likely when both APC and KRAS are mutated Progression more likely if APC mutated first Initiation of TADs explained by multiple mechanisms, not all of which are known Few CRCs have mutation of APC, KRAS & TP53 (Smith et al, PNAS 2002;99:9433)

7 KRAS and serrated polyps

8 RAS-RAF-MEK-ERK-MAP-kinase pathway and inhibition of apoptosis KRAS*: Up-regulation of prosurvival Akt/PKB: inactivation of caspase-9 and Bad BRAF*: Inhibition of cytosolic caspase activation following release of mitochondrial cytochrome c *Mutation of either confers resistance to DNA damageinduced apoptosis

9 Inhibition of apoptosis Loss of anchorage Integrin Basal lamina Cell membrane FAK/PI-3K Ras Akt/PKB caspase-2 caspase-7 caspase-3 caspase-9 Raf X X Bad Cytochrome c release from mitochondria

10 KRAS, BRAF and DNA methylation Ras RASSF1 Nore1 Raf RasGAP PI3-K Tiam1 Mst1 Mst1 MEK Rsk AKT Rac ERK Bad Casp9 IKK FKH Pro-apoptosis Bcl-2 Anti-apoptosis NF-κB

11 Pleiotropism of KRAS Hyperplastic ACF 100% Dysplastic ACF 63% Hyperplastic polyp 40% Serrated adenoma 20% Adenoma 15 to 75% CRC 35%

12 Pathogenesis of serrated polyps Inhibition of exfoliation Inhibition of apoptosis (anoikis) Retention of surface epithelium Cell senescence Growth by crypt fission

13 Incomplete apoptosis in SP Denatured CK18 without exfoliation? caspase-2 caspase-7 IHC M30/cytodeath CK18

14 CRC and CpG Island Methylation (CIMP)

15 Molecular classification of CRC Diploid Aneuploid MSI MSS Meth+ Meth

16 Features of CIMP-Pos/ MSS or MSI-L CRC MSI-High-like: Proximal, Mucinous, Poor diff, Serrated, F>M, BRAF+ Non-MSI-H-like: Early onset, few TILs, aggressive, meth MGMT, KRAS (when not BRAF+)

17 Serrated carcinoma in 17-year-old female MGMT

18 Serrated pathway to colorectal cancer

19 Classification of epithelial polyps Neoplastic* Adenoma (TA,TV,VA) Mixed polyp Serrated adenoma Non-neoplastic Hyperplastic polyp Spectrum of serrated polyps *Characterized by cancer-associated genetic alteration

20 HP-GC HP-MV SSP SA

21 Mixed polyps Collision? (HP and AD) Sequence? (HP to AD) - Identical genetic changes (MSI) in both components - Adenomatous component usually serrated

22 SA HP N D2S123

23 Serrated pathways BRAF/KRAS & DNA Meth MLH1 MP MSI-H CRC N HP MGMT MP MSI-L/ MSS CRC

24 BRAF and KRAS mutation in colorectal polyps TA TV HP SSP MP SA n.62 n.23 n.46 n.32 n.13 n.15 BRAF 3 (5%) 2 (9%) 30 (65%) 26 (81%) 7 (54%) 5 (33%) KRAS 11 (18%) 11 (48%) 1 (2%) 1 (3%) 6 (46%) 4 (27%)

25 Patterns of immunohistochemical expression of DNA repair genes Sporadic loss in hyperplastic crypts Loss in expanded and dysplastic subclones (when mutation gives growth advantage)

26

27 MLH1

28 MGMT

29 MGMT

30 HNPCC-like families with variable MSI status (Young et al. 2005)

31 Hyperplastic polyposis

32 Serrated pathway syndrome (SPS) (11 families from Qld Registry) MSI-variable CRC Mean age of onset 60 years/ F>M Variable polyp background (HP, SA mixed polyp, AD, SSA) Hyperplastic polyposis in up to 10% Concordant DNA methylation in polyps and cancers Concordant mutation of BRAF in most polyps and cancers Unrecognized (confused with HNPCC and FAP, low/mod penetrance and variable phenotype)

33 MGMT and fusion pathways to CRC

34 O-6-Methylguanine DNA Methyltransferase (MGMT) Overloaded MMR MSI-L MGMT methylation methylg:t mismatches Futile cycles of DNA repair CIN Demethylation* Mutation KRAS/TP53 *Nasr et al, Mutations of TP53 induce loss of DNA methylation Oncogene 2003;22:1668

35 Loss of MGMT in advanced serrated polyps (MP, SA, SSA) versus adenomas (Higuchi et al, 2005) Frequency R colon Size Type SP 24% Yes Yes NA AD 13% No No No

36 CRC arising in adenoma Re-expression of MGMT

37 Concept of fusion pathways 1. Adenoma APC TP53 2. Serrated polyp BRAF or KRAS DNA methylation

38 Concept of fusion pathways 1. Adenoma APC TP53 2. Serrated polyp BRAF or KRAS DNA methylation Fusion pathway A MGMT & KRAS Serration/villous

39 Concept of fusion pathways 1. Adenoma APC TP53 2. Serrated polyp BRAF or KRAS DNA methylation Fusion pathway A Fusion pathway B MGMT & KRAS Serration/villous APC/Wnt MGMT & TP53 MLH1 intact Dysplasia

40 MGMT MGMT 1. Adenoma with serration 2. Serrated polyp with dysplasia

41 Conclusion Not all adenomas or CRCs are initiated by APC mutation Most adenomas are dead-end lesions CRCs with DNA methylation are initiated by BRAF or KRAS (serrated pathway) and represent c. 25% of CRC

Serrated Polyps and a Classification of Colorectal Cancer

Serrated Polyps and a Classification of Colorectal Cancer Serrated Polyps and a Classification of Colorectal Cancer Ian Chandler June 2011 Structure Serrated polyps and cancer Molecular biology The Jass classification The familiar but oversimplified Vogelsteingram

More information

General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer

General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer Complexities of Pathological Assessment: Serrated Polyps/Adenomas Carolyn Compton, MD, PhD Professor of Life Sciences,

More information

Development of Carcinoma Pathways

Development of Carcinoma Pathways The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019

More information

Colon Cancer and Hereditary Cancer Syndromes

Colon Cancer and Hereditary Cancer Syndromes Colon Cancer and Hereditary Cancer Syndromes Gisela Keller Institute of Pathology Technische Universität München gisela.keller@lrz.tum.de Colon Cancer and Hereditary Cancer Syndromes epidemiology models

More information

Sessile Serrated Polyps

Sessile Serrated Polyps Årsmøtet i Den norske Patologforening 2014 Sessile Serrated Polyps Tor J. Eide Oslo Universitetssykehus The term serrated include a group of lesions with a sawtoothlike appearance of the crypts and the

More information

Arzu Ensari, MD, PhD Department of Pathology Ankara University Medical School

Arzu Ensari, MD, PhD Department of Pathology Ankara University Medical School Precursors of Colorectal Carcinoma Arzu Ensari, MD, PhD Department of Pathology Ankara University Medical School Hyperplastic polyp Adenomatous polyp Colorectal carcinoma IBD-associated (1-2%) Sporadic

More information

Disclosure slide I Member of advisory board for AMGEN, ROCHE, BOEHRINGER I Speaker honoraria from FALK Pharma, Pfizer, Lilly and ROCHE I Third party f

Disclosure slide I Member of advisory board for AMGEN, ROCHE, BOEHRINGER I Speaker honoraria from FALK Pharma, Pfizer, Lilly and ROCHE I Third party f Early (and not so early) colorectal cancer: The pathologist s point of view Daniela E. Aust, Institute for Pathology, University Hospital Dresden, Germany Disclosure slide I Member of advisory board for

More information

Early (and not so early) colorectal cancer: The pathologist s point of view

Early (and not so early) colorectal cancer: The pathologist s point of view Early (and not so early) colorectal cancer: The pathologist s point of view Daniela E. Aust, Institute for Pathology, University Hospital Dresden, Germany Disclosure slide I Member of advisory board for

More information

Serrated Lesions in the Bowel Cancer Screening Programme

Serrated Lesions in the Bowel Cancer Screening Programme Serrated Lesions in the Bowel Cancer Screening Programme Mark Arends Cambridge & Edinburgh Serrated Lesions of Large Bowel 1. Hyperplastic polyp 2. Serrated adenoma 3. Mixed polyp 4. Sessile serrated lesion

More information

General Surgery Grand Grounds

General Surgery Grand Grounds General Surgery Grand Grounds University of Colorado Health Sciences Center Case Presentation December 24, 2009 Adam Lackey, PGY-5 J.L. - 2111609 27 YO female with chief complaint of abdominal pain. PMHx:

More information

A WHO update on Serrated Polyps

A WHO update on Serrated Polyps A WHO update on Serrated Polyps Arzu Ensari, MD, PhD Department of Pathology Ankara University Medical School Am J Gastroenterol. 2010 Nov 2. [Epub ahead of The Clinical Significance of Serrated Polyps.

More information

Serrated Colorectal Polyps New Challenges to Old Dogma. Kenneth Batts, M.D. Abbott Northwestern Hospital Minneapolis, MN

Serrated Colorectal Polyps New Challenges to Old Dogma. Kenneth Batts, M.D. Abbott Northwestern Hospital Minneapolis, MN Serrated Colorectal Polyps New Challenges to Old Dogma Kenneth Batts, M.D. Abbott Northwestern Hospital Minneapolis, MN A Sneak Preview.... This was in the good old days: Adenomas HPPs Mixed Polyps A Sneak

More information

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of

More information

Hyperplastische Polyps Innocent bystanders?

Hyperplastische Polyps Innocent bystanders? Hyperplastische Polyps Innocent bystanders?? K. Geboes P th l i h O tl dk d Pathologische Ontleedkunde, KULeuven Content Historical Classification Relation Hyperplastic polyps carcinoma The concept cept

More information

Colonic Polyp. Najmeh Aletaha. MD

Colonic Polyp. Najmeh Aletaha. MD Colonic Polyp Najmeh Aletaha. MD 1 Polyps & classification 2 Colorectal cancer risk factors 3 Pathogenesis 4 Surveillance polyp of the colon refers to a protuberance into the lumen above the surrounding

More information

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of

More information

Genetic testing all you need to know

Genetic testing all you need to know Genetic testing all you need to know Sue Clark Consultant Colorectal Surgeon, St Mark s Hospital, London, UK. Colorectal cancer Familial 33% Polyposis syndromes

More information

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696 Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591

More information

Synchronous and Subsequent Lesions of Serrated Adenomas and Tubular Adenomas of the Colorectum

Synchronous and Subsequent Lesions of Serrated Adenomas and Tubular Adenomas of the Colorectum Tsumura T, et al 1 Synchronous and Subsequent Lesions of Serrated Adenomas and Tubular Adenomas of the Colorectum T. Tsumura a T. Hiyama d S. Tanaka b M. Yoshihara d K. Arihiro c K. Chayama a Departments

More information

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer TumorNet-Lynch genetic testing for hereditary colorectal or uterine cancer What Are the Causes of Hereditary Colorectal Cancer? sporadic 70% familial 20% hereditary 10% Lynch syndrome, up to 4% Familial

More information

Histo-prognostic factors what histopathology has to offer for clinical decision making

Histo-prognostic factors what histopathology has to offer for clinical decision making Histo-prognostic factors what histopathology has to offer for clinical decision making Daniela E. Aust Institute for Pathology, University Hospital Dresden, Germany Center for Molecular Tumor Diagnostics

More information

D uring the past few years, it has become

D uring the past few years, it has become 682 REVIEW My approach to serrated polyps of the colorectum T Higuchi, J R Jass... Hyperplastic polyps of the colorectum are heterogeneous lesions, a subset of which is now regarded as the precursor of

More information

Carcinogenesis in IBD

Carcinogenesis in IBD Oxford Inflammatory Bowel Disease MasterClass Carcinogenesis in IBD Dr Simon Leedham, Oxford, UK Oxford Inflammatory Bowel Disease MasterClass Carcinogenesis in Inflammatory Bowel Disease Dr Simon Leedham

More information

Serrated Colorectal Polyps and the Serrated Neoplasia Pathway

Serrated Colorectal Polyps and the Serrated Neoplasia Pathway Serrated Colorectal Polyps and the Serrated Neoplasia Pathway An update on the pathology and clinical significance Mark Be(ngton Envoi Specialist Pathologists Overview 1. A framework of what is included

More information

La genetica del carcinoma colo-rettale

La genetica del carcinoma colo-rettale La genetica del carcinoma colo-rettale Ivana Cataldo Ospedale Ca Foncello, Treviso ARC-NET Centro di Ricerca Applicata sul Cancro AOUI, Verona OUTLINE What s new in colorectal cancer? Pathological Markers

More information

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit

More information

Update on Colonic Serrated (and Conventional) Adenomatous Polyps

Update on Colonic Serrated (and Conventional) Adenomatous Polyps Update on Colonic Serrated (and Conventional) Adenomatous Polyps Maui, HI 2018 Robert D. Odze, MD, FRCPC Chief, Division of GI Pathology Professor of Pathology Brigham and Women s Hospital Harvard Medical

More information

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014 Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October

More information

Update on the serrated pathway to colorectal carcinoma

Update on the serrated pathway to colorectal carcinoma Human Pathology (2010) xx, xxx xxx www.elsevier.com/locate/humpath Progress in pathology Update on the serrated pathway to colorectal carcinoma Dale C. Snover MD Department of Pathology, Fairview Southdale

More information

Pathology of serrated colorectal lesions

Pathology of serrated colorectal lesions Correspondence to Dr Adrian C Bateman, Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, MP002, Level E, South Block, Southampton General Hospital, Tremona Road, Southampton

More information

The molecular genetics of colorectal cancer

The molecular genetics of colorectal cancer 1 Department of Gastroenterology, North Middlesex University Hospital, London, UK 2 Institute of Molecular Genetics, Cardiff University 3 Department of Gastroenterology, Queen s Hospital Romford, London,

More information

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000. Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma

More information

Serrated Polyps, Part 2: Their Mechanisms and Management Ryan C. Romano, DO

Serrated Polyps, Part 2: Their Mechanisms and Management Ryan C. Romano, DO Polyps, Part 2: Their Mechanisms and Management Ryan C. Romano, DO In the prelude to this article ( Polyps Part I: Their Confusing History) we discussed the evolution of colorectal serrated polyp classification,

More information

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38: Received November 13, 2015; Accepted March 11, DOI: /ijmm.2016.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38: Received November 13, 2015; Accepted March 11, DOI: /ijmm.2016. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38: 687-702 2016 Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and

More information

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?

More information

Pathology perspective of colonic polyposis syndromes

Pathology perspective of colonic polyposis syndromes Pathology perspective of colonic polyposis syndromes When are too many polyps too many? David Schaeffer Head and Consultant Pathologist, Department of Pathology and Laboratory Medicine, Vancouver General

More information

The MYH Gene Status in Patients with Sporadic Colorectal Polyps

The MYH Gene Status in Patients with Sporadic Colorectal Polyps Juan, I-Cheng PhD Thesis The MYH Gene Status in Patients with Sporadic Colorectal Polyps Wielkopolskie Centrum Onkologii w Poznaniu Poznan University of Medical Sciences Poland. ZaKład Immunologii Nowotworow.

More information

Colon cancer: practical molecular diagnostics. Wade S. Samowitz, M.D. University of Utah and ARUP

Colon cancer: practical molecular diagnostics. Wade S. Samowitz, M.D. University of Utah and ARUP Colon cancer: practical molecular diagnostics Wade S. Samowitz, M.D. University of Utah and ARUP Disclosure Dr. Samowitz may receive royalties in the future related to the Ventana BRAF V600E antibody.

More information

M. Azzam Kayasseh,Dubai,UAE

M. Azzam Kayasseh,Dubai,UAE Thanks A Lot Prof. Linda + Prof. Ernst #drkayasseh_crc_rsm #WEO_CRCSC #UEGW17 @dubaiendoscopyforum @drkayasseh.care.to.cure Twenty World Areas Age-Standardized CRC Incidence Rates by Sex GLOBOCAN 2008

More information

Multistep nature of cancer development. Cancer genes

Multistep nature of cancer development. Cancer genes Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic

More information

Carol A. Burke, MD, FACG

Carol A. Burke, MD, FACG Updated Guidelines for CRC C Screening and Surveillance Carol A. Burke MD, FACG, FASGE, FACP Cleveland Clinic, Cleveland, OH Gastroenterology t 2012;143:844 143 Gut 2010;59:666 1 Caveat for all Recommendations

More information

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics From clinic to genetics Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Autosomal dominant Question 2) Incidence of

More information

Molecular subtyping: how useful is it?

Molecular subtyping: how useful is it? Molecular subtyping: how useful is it? Daniela E. Aust, Institute for Pathology, University Hospital Dresden, Germany Center for Molecular Tumor Diagnostics at the NCT-Partner Site Dresden CMTD Disclosure

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal surgery prior as factor in laparoscopic colorectal surgery, 554 555 Abscess(es) CRC presenting as, 539 540 Adenocarcinoma of

More information

Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN

Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN Serrated Adenomas: What do they mean and what to do about them? Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN Colorectal Cancer Molecular Basis Pathway Frequency Genes MSI Precursor Speed

More information

Original Article Frequent CpG island methylation: a risk factor in the progression of traditional serrated adenoma of the colorectum

Original Article Frequent CpG island methylation: a risk factor in the progression of traditional serrated adenoma of the colorectum Int J Clin Exp Pathol 2017;10(9):9666-9674 www.ijcep.com /ISSN:1936-2625/IJCEP0045970 Original Article Frequent CpG island methylation: a risk factor in the progression of traditional serrated adenoma

More information

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor

More information

Clinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer

Clinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer Clinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer Shuji Ogino, M.D., Ph.D. Associate Professor of Pathology Harvard Medical School Brigham and Women s Hospital Dana-Farber

More information

The Natural History of Right-Sided Lesions

The Natural History of Right-Sided Lesions The Natural History of Right-Sided Lesions Jasper L.A. Vleugels Dept of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands. None Disclosures Agenda Is there evidence that

More information

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.

More information

Colorectal Cancer Screening and Surveillance

Colorectal Cancer Screening and Surveillance 1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal

More information

Microsatellite instability and other molecular markers: how useful are they?

Microsatellite instability and other molecular markers: how useful are they? Microsatellite instability and other molecular markers: how useful are they? Pr Frédéric Bibeau, MD, PhD Head, Pathology department CHU de Caen, Normandy University, France ESMO preceptorship, Barcelona,

More information

Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD

Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD Living Beyond Cancer A-Z January 12,2019 Hereditary CRC Syndromes Objectives are to discuss the : Most common Hereditary CRC syndromes

More information

Hereditary Gastric Cancer

Hereditary Gastric Cancer Hereditary Gastric Cancer Dr Bastiaan de Boer Consultant Pathologist Department of Anatomical Pathology PathWest Laboratory Medicine, QE II Medical Centre Clinical Associate Professor School of Pathology

More information

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015 WEO CRC SC Meeting Barcelona, Spain October 23, 2015 Identification of serrated polyposis syndrome in the context of population-based CRC screening programs Evelien Dekker Academic Medical Center Amsterdam,

More information

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer is not a single disease Ovarian Epithelial Tumors: Histological Spectrum* Type Frequency Histology High-Grade

More information

Research Article The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort

Research Article The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort Gastroenterology Research and Practice, Article ID 374926, 1 pages http://dx.doi.org/1.1155/214/374926 Research Article The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy

More information

Anatomic Molecular Pathology: An Emerging Field

Anatomic Molecular Pathology: An Emerging Field Anatomic Molecular Pathology: An Emerging Field Antonia R. Sepulveda M.D., Ph.D. University of Pennsylvania asepu@mail.med.upenn.edu 2008 ASIP Annual Meeting Anatomic pathology (U.S.) is a medical specialty

More information

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease) CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions

More information

Katarina Öhrling. Prognostic and Predictive Markers? Thesis for doctoral degree (Ph.D.) 2010

Katarina Öhrling. Prognostic and Predictive Markers? Thesis for doctoral degree (Ph.D.) 2010 Thesis for doctoral degree (Ph.D.) 2010 Thesis for doctoral degree (Ph.D.) 2010 Thymidylate Synthase Expression and Mismatch Repair Protein Expression in Colorectal Cancer Thymidylate Synthase Expression

More information

Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer

Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer GASTROENTEROLOGY 2008;34:950 960 Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer TAKESHI NAGASAKA,* MINORU KOI,* MATTHIAS KLOOR, JOHANNES GEBERT, ALEX VILKIN,*

More information

Arthur Purdy Stout Society of Surgical Pathologists Companion Meeting. Microsatellite Instability and Serrated Adenomas in Common Practice

Arthur Purdy Stout Society of Surgical Pathologists Companion Meeting. Microsatellite Instability and Serrated Adenomas in Common Practice Arthur Purdy Stout Society of Surgical Pathologists Companion Meeting Microsatellite Instability and Serrated Adenomas in Common Practice United States and Canadian Academy of Pathology Annual Meeting

More information

Management of higher risk of colorectal cancer. Huw Thomas

Management of higher risk of colorectal cancer. Huw Thomas Management of higher risk of colorectal cancer Huw Thomas Colorectal Cancer 41,000 new cases pa in UK 16,000 deaths pa 60% 5 year survival Adenoma-carcinoma sequence (Morson) Survival vs stage (Dukes)

More information

Supplementary Table 1. PIK3CA mutation in colorectal cancer

Supplementary Table 1. PIK3CA mutation in colorectal cancer Liao X et al. PIK3CA Mutation in Colorectal Cancer. Page 1 Supplementary Table 1. PIK3CA mutation in colorectal cancer Exon Domain Nucleotide change* Amino acid change* cases 9 Helical c.1621t>a p.e541t

More information

NIH Public Access Author Manuscript Gastroenterology. Author manuscript; available in PMC 2009 June 1.

NIH Public Access Author Manuscript Gastroenterology. Author manuscript; available in PMC 2009 June 1. NIH Public Access Author Manuscript Published in final edited form as: Gastroenterology. 2008 June ; 134(7): 1950 1960.e1. doi:10.1053/j.gastro.2008.02.094. Mutations in both KRAS and BRAF may contribute

More information

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry FAMILIAL COLORECTAL CANCER Lyn Schofield Manager Familial Cancer Registry Cancer in WA 2004 4000 3500 ASPR, rate per 100,000 3000 2500 2000 1500 1000 Male incidence Female incidence Male mortality Female

More information

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit. Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is

More information

Genetic Modifiers of Chemotherapy for Colorectal Cancer

Genetic Modifiers of Chemotherapy for Colorectal Cancer Genetic Modifiers of Chemotherapy for Colorectal Cancer September 27, 2011 John M. Carethers, M.D. Professor of Internal Medicine University of Michigan 1,233,700 cases/year Worldwide ~146,000 cases/year

More information

The silence of the genes: clinical applications of (colorectal) cancer epigenetics

The silence of the genes: clinical applications of (colorectal) cancer epigenetics The silence of the genes: clinical applications of (colorectal) cancer epigenetics Manon van Engeland, PhD Dept. of Pathology GROW - School for Oncology & Developmental Biology Maastricht University Medical

More information

Marcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari

Marcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari Marcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari Milo Frattini XII Congresso AIFEG Villa Cagnola - Gazzada Schianno (VA) 16/17.10.2014 APC β-catenina APC Met (p16) Models of

More information

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018 colorectal cancer Adenocarcinoma of the colon and rectum is the third most common site of new cancer cases and deaths in men (following prostate and lung or bronchus cancer) and women (following breast

More information

The Clinical Significance of Serrated Polyps

The Clinical Significance of Serrated Polyps CLINICAL AND SYSTEMATIC S nature publishing group 229 CME The Clinical Significance of Serrated Polyps Christopher S. Huang, MD 1, Fr anc is A. Far raye, M D, M S c 1, Sh i Yang, M D 2 and Michael J. O

More information

Determination Differentiation. determinated precursor specialized cell

Determination Differentiation. determinated precursor specialized cell Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:

More information

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change

More information

Sessile serrated polyps: Cancer risk and appropriate surveillance

Sessile serrated polyps: Cancer risk and appropriate surveillance REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will understand the role of the recently recognized serrated neoplasia pathway in the development of colorectal cancer ROHIT MAKKAR, MD St. Michael s Hospital,

More information

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS

More information

The Importance of Complete Colonoscopy and Exploration of the Cecal Region

The Importance of Complete Colonoscopy and Exploration of the Cecal Region The Importance of Complete Colonoscopy and Exploration of the Cecal Region Kuangi Fu, Takahiro Fujii, Takahisa Matsuda, and Yutaka Saito 2 2.1 The Importance of a Complete Colonoscopy Ever since case-control

More information

Colorectal Carcinoma Reporting in 2009

Colorectal Carcinoma Reporting in 2009 Colorectal Carcinoma Reporting in 2009 Overview Colorectal carcinoma- new and confusing AJCC TNM issues Wendy L. Frankel, M.D. Vice-Chair and Director of AP Department of Pathology The Ohio State University

More information

DNA methylation: An important mechanism in colorectal carcinogenesis and pretumor progression

DNA methylation: An important mechanism in colorectal carcinogenesis and pretumor progression Ittai Bernardo Muller Student no. 3257886 DNA methylation: An important mechanism in colorectal carcinogenesis and pretumor progression June 2011 Biomedical Sciences University Utrecht Thesis This thesis

More information

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately

More information

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome of Lynch Syndrome: guidelines 17/03/2009 Content Terminology Lynch Syndrome Presumed Lynch Syndrome Familial Colorectal Cancer Identification of Lynch Syndrome Amsterdam II criteria Revised Bethesda Guidelines

More information

Colon Cancer Screening & Surveillance. Amit Patel, MD PGY-4 GI Fellow

Colon Cancer Screening & Surveillance. Amit Patel, MD PGY-4 GI Fellow Colon Cancer Screening & Surveillance Amit Patel, MD PGY-4 GI Fellow Epidemiology CRC incidence and mortality rates vary markedly around the world. Globally, CRC is the third most commonly diagnosed cancer

More information

Molecular Diagnosis for Colorectal Cancer Patients

Molecular Diagnosis for Colorectal Cancer Patients Molecular Diagnosis for Colorectal Cancer Patients Antonia R. Sepulveda MD, PhD, FCAP October, 20, 2010 www.cap.org Welcome to the PHC Webinar Series This talk on The Molecular Diagnosis for Colorectal

More information

Disclaimer: I belong to the speakers bureau of the American Serrated Society, often referred to as the ASS

Disclaimer: I belong to the speakers bureau of the American Serrated Society, often referred to as the ASS An Exposé on Serrated Lesions of the Colorectum How do you know it is a hyperplastic polyp and not something else? How do you know it is something else and not a hyperplastic polyp? Disclaimer: I belong

More information

Sessile Serrated Polyps: An Important Route to Colorectal Cancer

Sessile Serrated Polyps: An Important Route to Colorectal Cancer Focused Review 1585 Sessile Serrated Polyps: An Important Route to Colorectal Cancer Matthew F. Kalady, MD Abstract The serrated neoplastic pathway accounts for approximately 30% of colorectal cancers.

More information

Colon Cancer Update Christie J. Hilton, DO

Colon Cancer Update Christie J. Hilton, DO POMA Winter Conference Christie Hilton DO Medical Oncology January 2018 None Colon Cancer Numbers Screening (brief update) Practice changing updates in colon cancer MSI Testing Immunotherapy in Colon Cancer

More information

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer January 2015 1 Background Mismatch repair (MMR) deficiency is seen in approximately

More information

Molecular pathogenesis of serrated carcinoma of the colon

Molecular pathogenesis of serrated carcinoma of the colon Molecular pathogenesis of serrated carcinoma of the colon Winnie Collet Fernando Master of Molecular Biology Bachelor of Technology in Industrial Biotechnology Griffith School of Biomolecular and Physical

More information

Hyperplastic polyps in hereditary nonpolyposis colorectal cancer

Hyperplastic polyps in hereditary nonpolyposis colorectal cancer 4 Hyperplastic polyps in hereditary nonpolyposis colorectal cancer F E M Rijcken 1, T van der Sluis 2, H Hollema 2, J H Kleibeuker 1 Department of Gastroenterology 1 and Pathology 2, University Medical

More information

GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome

GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By HENRY T. LYNCH, M.D. 1 Could this be hereditary Colon Cancer 4 Creighton University School of Medicine Omaha, Nebraska Magnitude of the Problem Annual

More information

Universal Screening for Lynch Syndrome

Universal Screening for Lynch Syndrome Universal Screening for Lynch Syndrome St. Vincent/Ameripath protocol proposal Lynch syndrome (HNPCC) 1/35 individuals with colorectal cancer has Lynch syndrome Over half individuals are >50 at time of

More information

Review Article Serrated Polyposis: An Enigmatic Model of Colorectal Cancer Predisposition

Review Article Serrated Polyposis: An Enigmatic Model of Colorectal Cancer Predisposition SAGE-Hindawi Access to Research Pathology Research International Volume 2011, Article ID 157073, 13 pages doi:10.4061/2011/157073 Review Article Serrated Polyposis: An Enigmatic Model of Colorectal Cancer

More information

Noninvasive Molecular Detection of Colorectal Neoplasia

Noninvasive Molecular Detection of Colorectal Neoplasia Disclosures Noninvasive Molecular Detection of Colorectal Next Generation Approaches David Ahlquist August 7, 29 Relationship with Exact Sciences Mayo Clinic is equity investor Potential for future royalties

More information

Hereditary Cancer Syndromes

Hereditary Cancer Syndromes Hereditary Cancer Syndromes Nicoleta Voian, MD, MPH Director Clinical Genetics Service Roswell Park Cancer Institute Nicoleta.Voian@Roswellpark.org February 28, 2017 Common Genetics Terms Gene: A hereditary

More information

Molecular biology of colorectal cancer

Molecular biology of colorectal cancer Molecular biology of colorectal cancer Phil Quirke Yorkshire Cancer Research Centenary Professor of Pathology University of Leeds, UK Rapid pace of molecular change Sequencing changes 2012 1,000 genomes

More information

Molecular markers in colorectal cancer. Wolfram Jochum

Molecular markers in colorectal cancer. Wolfram Jochum Molecular markers in colorectal cancer Wolfram Jochum Biomarkers in cancer Patient characteristics Tumor tissue Normal cells Serum Body fluids Predisposition Diagnostic marker Specific diagnosis Prognostic

More information

Title: Serrated polyposis syndrome associated with long-standing inflammatory bowel disease

Title: Serrated polyposis syndrome associated with long-standing inflammatory bowel disease Title: Serrated polyposis syndrome associated with long-standing inflammatory bowel disease Authors: Jesús Castro, Miriam Cuatrecasas, Francesc Balaguer, Elena Ricart, María Pellisé DOI: 10.17235/reed.2017.5068/2017

More information

6 semanas de embarazo. Tubulovillous adenoma with dysplasia icd 10. Inicio / Embarazo / 6 semanas de embarazo

6 semanas de embarazo. Tubulovillous adenoma with dysplasia icd 10. Inicio / Embarazo / 6 semanas de embarazo Inicio / Embarazo / 6 semanas de embarazo 6 semanas de embarazo Tubulovillous adenoma with dysplasia icd 10 Free, official coding info for 2018 ICD-10-CM D13.2 - includes detailed rules, notes, synonyms,

More information

Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice?

Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? Virchows Arch (2007) 450:613 618 DOI 10.1007/s00428-007-0413-8 ORIGINAL ARTICLE Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice?

More information

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth

More information